Distinguished in Embryonal Tumor with Multilayered Rosettes

Dr. Rupesh R. Kotecha

Radiation Oncology
Baptist Health Medical Group Oncology LLC
8900 N Kendall Dr, 
Miami, FL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Distinguished in Embryonal Tumor with Multilayered Rosettes
Baptist Health Medical Group Oncology LLC
8900 N Kendall Dr, 
Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rupesh Kotecha is a Radiation Oncologist in Miami, Florida. Dr. Kotecha is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Brain Tumor, Astrocytoma, Glioblastoma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Kotecha is currently accepting new patients.

His clinical research consists of co-authoring 232 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Embryonal Tumor with Multilayered Rosettes.

Specialties
Radiation Oncology
Licenses
Radiology in FL
Hospital Affiliations
Baptist Hospital Of Miami
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
SummaCare
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

BAPTIST HEALTH MEDICAL GROUP ONCOLOGY LLC
8900 N Kendall Dr, Miami, FL 33176

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Characterization of Large Brain Metastases With 18F-Fluciclovine PET/CT Treated With Staged Stereotactic Radiosurgery
Characterization of Large Brain Metastases With 18F-Fluciclovine PET/CT Treated With Staged Stereotactic Radiosurgery
Enrollment Status: Recruiting
Publish Date: September 24, 2025
Intervention Type: Drug
Study Drug: 18F fluciclovine
Study Phase: Phase 1
A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma
A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma
Enrollment Status: Recruiting
Publish Date: May 22, 2025
Intervention Type: Drug
Study Phase: Phase 2
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2025
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas
A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Temozolomide
Study Phase: Phase 2
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: April 23, 2025
Intervention Type: Drug, Device
Study Phase: Phase 2
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Randomized Phase II Study of Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation for Localized Spine Metastasis
Randomized Phase II Study of Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation for Localized Spine Metastasis
Enrollment Status: Active_not_recruiting
Publish Date: February 04, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug, Device
Study Drug: Immune checkpoint inhibitors or docetaxel
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
View 8 Less Clinical Trials

224 Total Publications

Current Status of Proton Craniospinal Irradiation for Solid Tumor Leptomeningeal Disease.
Current Status of Proton Craniospinal Irradiation for Solid Tumor Leptomeningeal Disease.
Journal: Practical radiation oncology
Published: June 09, 2025
Similar Doctors
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Matthew Hall
Radiation Oncology
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Matthew Hall
Radiation Oncology

Baptist Health Medical Group Oncology LLC

1228 S Pine Island Rd, Suite 410, 
Plantation, FL 
 (29.5 miles away)
954-837-1490
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Matthew Hall is a Radiation Oncologist in Plantation, Florida. Dr. Hall is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Merkel Cell Carcinoma, Gliomatosis Cerebri, Embryonal Tumor with Multilayered Rosettes, and Ependymoma.

Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Matthew C. Abramowitz
Radiation Oncology
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Matthew C. Abramowitz
Radiation Oncology

University Of Miami

1611 Nw 12 Th Ave, Jackson Memorial Hospital, 
Miami, FL 
 (10.9 miles away)
305-355-5000
Languages Spoken:
English, Hindi, Marathi, Spanish, Swahili
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Abramowitz is a Radiation Oncologist in Miami, Florida. Dr. Abramowitz is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Astrocytoma, Embryonal Tumor with Multilayered Rosettes, and Prostatectomy. Dr. Abramowitz is currently accepting new patients.

Advanced in Embryonal Tumor with Multilayered Rosettes
Dr. Laura M. Freedman
Radiation Oncology
Advanced in Embryonal Tumor with Multilayered Rosettes
Dr. Laura M. Freedman
Radiation Oncology

University Of Miami

1601 Nw 12th Ave, 
Miami, FL 
 (10.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Laura Freedman is a Radiation Oncologist in Miami, Florida. Dr. Freedman is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Laryngeal Cancer, Adenoid Cystic Carcinoma, Throat Cancer, Small Cell Lung Cancer (SCLC), and Gastrostomy. Dr. Freedman is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kotecha's expertise for a condition
ConditionClose
View All 16 Distinguished Conditions
View All 11 Advanced Conditions
View All 43 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile